首页> 外文期刊>Annals of Coloproctology >Sensitivity of Various Evaluating Modalities for Predicting a Pathologic Complete Response After Preoperative Chemoradiation Therapy for Locally Advanced Rectal Cancer
【24h】

Sensitivity of Various Evaluating Modalities for Predicting a Pathologic Complete Response After Preoperative Chemoradiation Therapy for Locally Advanced Rectal Cancer

机译:各种评价术语术前化学疗法术前预测局部晚肠癌术后病理完全反应的敏感性

获取原文
           

摘要

Purpose: We investigated the sensitivity of various evaluating modalities in predicting a pathologic complete response(pCR) after preoperative chemoradiation therapy (PCRT) for locally advanced rectal cancer (LARC).Methods: From a population of 2,247 LARC patients who underwent PCRT followed by surgery at Asan Medical Center,Seoul, Korea from January 2007 to June 2016, we retrospectively analyzed 313 patients (14.1%) who showed a pCR aftersurgery. Transrectal ultrasound (TRUS), high-resolution magnetic resonance imaging (MRI), abdominopelvic computedtomography (AP-CT), and endoscopy were performed within 2 weeks prior to surgery.Results: Of the 313 patients analyzed, 256 (81.8%) had a pCR after radical surgery and 57 (18.2%) showed total regressionafter local excision. Preoperative TRUS, MRI, and AP-CT were performed in 283, 305, and 139 patients, respectively.Among these 3 groups, a prediction of a pCR of the primary tumor was made in 41 (14.5%), 51 (16.7%), and 27 patients(19.4%), respectively, before surgery. A prediction of a clinical N0 stage was made in 204 patients (88.3%) using TRUS,130 (52.2%) using MRI, and 78 (65.5%) using AP-CT. Of the 211 patients who underwent endoscopy, 87 (41.2%) had amention of clinical CR in their records. A prediction of a pathologic CR was made for 124 patients (39.6%) through atleast one diagnostic modality.Conclusion: The various evaluation methods for predicting a pCR after PCRT show a predictive sensitivity of 0.15–0.41for primary tumors and 0.52–0.88 for lymph nodes. Endoscopy is a relatively superior modality for predicting the pCR ofthe primary tumor of LARC patients.
机译:目的:我们研究了各种评价术语术前化学疗法(PCRT)在局部晚期直肠癌(LARC)后的病理完全反应(PCR)的敏感性。方法:来自2,247例患者的患者,接受PCRT的患者,然后进行手术在2007年1月至2016年6月,韩国朝鲜医疗中心,我们回顾性地分析了313名患者(14.1%),他们展示了PCR备用症。经术超声(TRUS),高分辨率磁共振成像(MRI),腹部阑尾计算(AP-CT)和内窥镜检查是在手术前的2周内进行的。结果:313名患者分析,256名(81.8%)有一个PCR自由基手术和57(18.2%)显示出局部局部切除率总数。在283,305和139名患者中,在283,305和139名患者中进行术前Trus,MRI和AP-CT,在41(14.5%),51(16.7%)中制备了原发性肿瘤的PCR的预测和27名患者(19.4%)分别在手术前。使用MRI的TRU,130(52.2%)和使用AP-CT,在204名患者(88.3%)中预测临床N0阶段(88.3%)。使用AP-CT,78(65.5%)。在接受内窥镜检查的211名患者中,87名(41.2%)在其记录中有临床CR的衰减。通过至少一种诊断方式对124名患者(39.6%)进行病理CR的预测。结论:PCRT后预测PCR的各种评价方法显示出对原发性肿瘤0.15-0.41的预测敏感性和淋巴的0.52-0.88节点。内镜检查是一种相对优越的方式,用于预测LARC患者的主要肿瘤的PCR。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号